Previous close | 74.32 |
Open | 74.68 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 74.23 - 74.79 |
52-week range | 74.23 - 74.79 |
Volume | |
Avg. volume | N/A |
Market cap | 96.038B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | 13.59 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The market has been more pessimistic about CVS Health (NYSE: CVS), whose shares have crashed 28% in the last 12 months, falling significantly more than the broader market. The S&P 500 index lost just 12% over the same period, while The Health Care Select Sector SPDR Fund (of which CVS Health is a constituent) fell only 7.4%. Let's go through the arguments in favor of buying it now, and ones that takes the opposite position, so you can assess whether CVS Health a good pick to help meet your investing goals.
CVS Health (CVS) closed at $74.70 in the latest trading session, marking a +0.82% move from the prior day.
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?